Heiko Schöder, MD, MBA
Radiologist & Nuclear Medicine Physician
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
My Specialties
- PET/CT Body Imaging in Oncology
- Cardiac Imaging
- General Diagnostic and Therapeutic Nuclear Medicine
About Me
- Chief, Molecular Imaging and Therapy Service
I am a nuclear medicine physician and Chief of the Molecular Imaging and Therapy Service in the Department of Radiology. I have special expertise in oncologic imaging (in particular using PET/CT), as well as cardiac imaging and nuclear medicine therapies.
I am an active member of several national and international imaging societies, including the Society of Nuclear Medicine and Molecular Imaging, for which I organize and participate in regular educational lecture series. As an imaging expert, I have organized and participated in numerous national and international multicenter clinical trials. I am a regular reviewer for leading imaging and oncology journals. I have been elected fellow of the Society of Nuclear Medicine and Molecular Imaging. Besides my clinical work, I am interested in how the medical industry is changing and the future of healthcare.
Read more
I am actively involved in clinical research. My current research interests include: assessing the role of PET/CT imaging in the management of cancer patients, in particular patients with lymphoma, as well as cancers of the head and neck and genitourinary tract; the introduction and clinical evaluation of new PET radiotracers in oncology; the role of PET/CT imaging in radiotherapy planning and response assessment; and the development and evaluation of new radiopharmaceuticals for radiotheranostics.
I am a member of the disease management teams for lymphoma and head and neck cancer at MSK.
A radiologist is a doctor with special training in using imaging to diagnose and treat disease. Imaging includes X-rays, computed tomography (CT), and magnetic resonance imaging (MRI).
A nuclear medicine physician is a doctor with special training in using radioactive drugs to diagnose and treat disease.
My Specialties
- PET/CT Body Imaging in Oncology
- Cardiac Imaging
- General Diagnostic and Therapeutic Nuclear Medicine
Education
- MD, Humboldt University (Berlin)
- MBA, Yale School of Management
Residencies
- University of California, Los Angeles, Medical Center
Fellowships
- University of California, Los Angeles, Medical Center
Board Certifications
- Nuclear Medicine (US)
- Nuclear Cardiology (US)
- Diagnostic Radiology and Nuclear Medicine (Germany)
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
PPO, HMO, DSN
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
Contact and Location
Dr. Schöder sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Co-Investigated by Dr. Schöder
- A Phase 3 Double-Blinded Randomized Study Comparing Personalized Chemotherapy and Radiation Therapy With Standard Chemotherapy and Radiation Therapy in People With HPV-Positive Throat Cancer
- A Phase II Study Assessing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
- A Phase II Study of Pembrolizumab Immunotherapy plus Chemotherapy followed by Autologous Stem Cell Transplantation for Recurrent or Persistent Hodgkin Lymphoma
- A Study of Significantly Reduced Radiation Therapy and Reduced Chemotherapy in People with HPV-Positive Throat Cancer
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Schöder’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Heiko Schöder discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].